TECTONIC THERAPEUTIC, INC. (TECX) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
19/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LoseTECX / S&P 11.23% / 15.20% |
LoseTECX / S&P TECX unavailable / 15.00% |
WinTECX / S&P 59.23% / 50.40% |
| 2026-Q11/3 |
WinTECX / S&P 48.18% / -4.33% |
LoseTECX / S&P TECX unavailable / 11.30% |
LoseTECX / S&P -27.36% / 27.70% |
| 2025-Q41/3 |
WinTECX / S&P 32.95% / 2.65% |
LoseTECX / S&P TECX unavailable / 9.00% |
LoseTECX / S&P -74.97% / 13.40% |
| 2025-Q30/3 |
LoseTECX / S&P -21.04% / 8.12% |
LoseTECX / S&P TECX unavailable / 4.61% |
LoseTECX / S&P -87.89% / 13.45% |
| 2025-Q21/3 |
WinTECX / S&P 12.20% / 10.94% |
LoseTECX / S&P TECX unavailable / 4.83% |
LoseTECX / S&P -89.98% / 10.63% |
| 2025-Q10/3 |
LoseTECX / S&P -61.64% / -4.27% |
LoseTECX / S&P TECX unavailable / 4.98% |
LoseTECX / S&P -81.28% / 10.57% |
| 2024-Q41/3 |
WinTECX / S&P 52.38% / 2.41% |
LoseTECX / S&P TECX unavailable / 5.25% |
LoseTECX / S&P -27.77% / 6.15% |
| 2024-Q32/3 |
WinTECX / S&P 83.97% / 5.89% |
LoseTECX / S&P TECX unavailable / 5.89% |
WinTECX / S&P 28.60% / 6.11% |
| 2024-Q22/3 |
WinTECX / S&P 7.23% / 4.28% |
LoseTECX / S&P TECX unavailable / 5.38% |
WinTECX / S&P 181.51% / 5.12% |
| 2024-Q11/3 |
LoseTECX / S&P -5.88% / 10.56% |
LoseTECX / S&P TECX unavailable / 5.71% |
WinTECX / S&P 1326.09% / 5.59% |
| 2023-Q41/3 |
LoseTECX / S&P -11.69% / 11.69% |
LoseTECX / S&P TECX unavailable / 6.81% |
WinTECX / S&P 829.46% / 7.78% |
| 2023-Q32/3 |
WinTECX / S&P 62.11% / -3.27% |
LoseTECX / S&P TECX unavailable / 7.52% |
WinTECX / S&P 593.57% / -5.03% |
| 2023-Q21/3 |
LoseTECX / S&P -5.00% / 8.74% |
LoseTECX / S&P TECX unavailable / 9.50% |
WinTECX / S&P 273.90% / -8.57% |
| 2023-Q11/3 |
WinTECX / S&P 40.85% / 7.50% |
LoseTECX / S&P TECX unavailable / 10.77% |
LoseTECX / S&P -18.44% / -15.69% |
| 2022-Q41/3 |
WinTECX / S&P 10.94% / 7.56% |
LoseTECX / S&P TECX unavailable / 11.88% |
LoseTECX / S&P TECX unavailable / -17.99% |
| 2022-Q30/3 |
LoseTECX / S&P -30.43% / -4.88% |
LoseTECX / S&P TECX unavailable / 13.47% |
LoseTECX / S&P TECX unavailable / -1.41% |
| 2022-Q20/3 |
LoseTECX / S&P -30.30% / -16.10% |
LoseTECX / S&P TECX unavailable / 13.71% |
LoseTECX / S&P TECX unavailable / 11.04% |
| 2022-Q10/3 |
LoseTECX / S&P -65.71% / -4.60% |
LoseTECX / S&P TECX unavailable / 15.97% |
LoseTECX / S&P TECX unavailable / 42.23% |
| 2021-Q40/3 |
LoseTECX / S&P -31.00% / 11.03% |
LoseTECX / S&P TECX unavailable / 15.00% |
LoseTECX / S&P TECX unavailable / 96.40% |
| 2021-Q30/3 |
LoseTECX / S&P -37.23% / 0.58% |
LoseTECX / S&P TECX unavailable / 10.77% |
LoseTECX / S&P TECX unavailable / 69.42% |
| 2021-Q20/3 |
LoseTECX / S&P -29.94% / 8.55% |
LoseTECX / S&P TECX unavailable / 6.58% |
LoseTECX / S&P TECX unavailable / 51.81% |
| 2021-Q10/3 |
LoseTECX / S&P -8.97% / 6.17% |
LoseTECX / S&P TECX unavailable / -1.06% |
LoseTECX / S&P TECX unavailable / 7.39% |
| 2020-Q40/3 |
LoseTECX / S&P 7.07% / 12.15% |
LoseTECX / S&P TECX unavailable / -3.72% |
LoseTECX / S&P TECX unavailable / -33.42% |
| 2020-Q30/3 |
LoseTECX / S&P -25.39% / 8.93% |
LoseTECX / S&P TECX unavailable / -2.04% |
LoseTECX / S&P TECX unavailable / -27.10% |
| 2020-Q20/3 |
LoseTECX / S&P 12.15% / 20.54% |
LoseTECX / S&P TECX unavailable / -0.46% |
LoseTECX / S&P TECX unavailable / -27.11% |
| 2020-Q10/3 |
LoseTECX / S&P -22.70% / -19.60% |
LoseTECX / S&P TECX unavailable / 3.47% |
LoseTECX / S&P TECX unavailable / -14.75% |
| 2019-Q41/3 |
WinTECX / S&P 42.56% / 9.07% |
LoseTECX / S&P TECX unavailable / 5.36% |
LoseTECX / S&P TECX unavailable / 2.99% |
| 2019-Q30/3 |
LoseTECX / S&P -13.16% / 1.70% |
LoseTECX / S&P TECX unavailable / 5.02% |
LoseTECX / S&P TECX unavailable / 0.21% |
| 2019-Q20/3 |
LoseTECX / S&P -26.26% / 4.30% |
LoseTECX / S&P TECX unavailable / 6.64% |
LoseTECX / S&P TECX unavailable / 8.65% |
| 2019-Q11/3 |
WinTECX / S&P 32.43% / 13.65% |
LoseTECX / S&P TECX unavailable / 8.12% |
LoseTECX / S&P TECX unavailable / 14.29% |
| 2018-Q40/3 |
LoseTECX / S&P -67.90% / -13.52% |
LoseTECX / S&P TECX unavailable / 9.05% |
LoseTECX / S&P TECX unavailable / 18.23% |
| 2018-Q31/3 |
WinTECX / S&P 81.62% / 7.71% |
LoseTECX / S&P TECX unavailable / 10.21% |
LoseTECX / S&P TECX unavailable / 19.06% |
| 2018-Q20/3 |
LoseTECX / S&P TECX unavailable / 3.43% |
LoseTECX / S&P TECX unavailable / 9.03% |
LoseTECX / S&P TECX unavailable / 14.46% |
| 2018-Q10/3 |
LoseTECX / S&P TECX unavailable / -0.76% |
LoseTECX / S&P TECX unavailable / 7.68% |
LoseTECX / S&P TECX unavailable / 12.46% |
| 2017-Q40/3 |
LoseTECX / S&P TECX unavailable / 6.64% |
LoseTECX / S&P TECX unavailable / 7.03% |
LoseTECX / S&P TECX unavailable / 13.82% |
| 2017-Q30/3 |
LoseTECX / S&P TECX unavailable / 4.48% |
LoseTECX / S&P TECX unavailable / 5.68% |
LoseTECX / S&P TECX unavailable / 17.57% |
| 2017-Q20/3 |
LoseTECX / S&P TECX unavailable / 3.09% |
LoseTECX / S&P TECX unavailable / 4.83% |
LoseTECX / S&P TECX unavailable / 17.74% |
| 2017-Q10/3 |
LoseTECX / S&P TECX unavailable / 6.07% |
LoseTECX / S&P TECX unavailable / 3.67% |
LoseTECX / S&P TECX unavailable / 13.32% |
| 2016-Q40/3 |
LoseTECX / S&P TECX unavailable / 3.82% |
LoseTECX / S&P TECX unavailable / 2.09% |
LoseTECX / S&P TECX unavailable / 7.05% |
| 2016-Q30/3 |
LoseTECX / S&P TECX unavailable / 3.85% |
LoseTECX / S&P TECX unavailable / 0.20% |
LoseTECX / S&P TECX unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | TECX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 43.70% | 20.78% |
| Annualized return | 43.70% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | TECX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -54.76% | 83.14% |
| Annualized return | -14.67% | 12.86% |
10Y · 2018-06-21 to 2026-08-27
| Metric | TECX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -90.20% | 319.30% |
| Annualized return | -20.73% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |